Anti-Human IgG Fc C-terminus Antibody

<strong>Anti-Human IgG Fc C-terminus Antibody</strong>_x000D_ <strong>Catalog number:</strong> B2014747_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 vial_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Anti-Human IgG Fc C-terminus Monoclonal Antibody_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Nelson PN, Westwood OM, Soltys A, Jefferis R, Goodall M, Baumforth KR, Frampton G, Tribbick G, Roden D, Hay FC. Characterisation of epitopes of pan-IgG/anti-G3m(u) and anti-Fc monoclonal antibodies Immunol Lett. 2003 Jul 3;88(1):77-83._x000D_ 2: Budzianowski J. Tobacco against Ebola virus disease Przegl Lek. 2015;72(10):567-71._x000D_ 3: Kim HS, Kim I, Zheng L, Vernes JM, Meng YG, Spiess C. Evading pre-existing anti-hinge antibody binding by hinge engineering MAbs. 2016 Nov/Dec;8(8):1536-1547._x000D_ 4: Falkenburg WJJ, Kempers AC, Dekkers G, Ooijevaar-de Heer P, Bentlage AEH, Vidarsson G, van Schaardenburg D, Toes REM, Scherer HU, Rispens T. Rheumatoid factors do not preferentially bind to ACPA-IgG or IgG with altered galactosylation Rheumatology (Oxford). 2017 Nov 1;56(11):2025-2030._x000D_ 5: Rossi EA, Chang CH, Cardillo TM, Goldenberg DM. Optimization of multivalent bispecific antibodies and immunocytokines with improved in vivo properties Bioconjug Chem. 2013 Jan 16;24(1):63-71._x000D_ 6: Thueng-in K, Thanongsaksrikul J, Jittavisutthikul S, Seesuay W, Chulanetra M, Sakolvaree Y, Srimanote P, Chaicumpa W. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase MAbs. 2014;6(5):1327-39._x000D_ 7: Hintersteiner B, Lingg N, Zhang P, Woen S, Hoi KM, Stranner S, Wiederkum S, Mutschlechner O, Schuster M, Loibner H, Jungbauer A. Charge heterogeneity: Basic antibody charge variants with increased binding to Fc receptors MAbs. 2016 Nov/Dec;8(8):1548-1560._x000D_ 8: Gachet C, Astier A, de la Salle H, de la Salle C, Fridman WH, Cazenave JP, Hanau D, Teillaud JL. Release of Fc gamma RIIa2 by activated platelets and inhibition of anti-CD9-mediated platelet aggregation by recombinant Fc gamma RIIa2 Blood. 1995 Feb 1;85(3):698-704._x000D_ 9: Jewett A. Activation of c-Jun N-terminal kinase in the absence of NFkappaB function prior to induction of NK cell death triggered by a combination of anti-class I and anti-CD16 antibodies Hum Immunol. 2001 Apr;62(4):320-31._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/2434846">10: Partridge LJ, Woof JM, Jefferis R, Burton DR. The use of anti-IgG monoclonal antibodies in mapping the monocyte receptor site on IgG Mol Immunol. 1986 Dec;23(12):1365-72. </a>_x000D_ _x000D_ <strong>Products Related to Anti-Human IgG Fc C-terminus Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>